Article

Molecular Characterization of a Long Term Survivor Double Metastatic Non Small Sell Lung Cancer and Pancreatic Ductal Adenocarcinoma Treated with Gefitinib in Combination with Gemcitabine Plus Nab-Paclitaxel and mFOLFOX6 as First and Second Line Therapy

2019-05-14

Abstract excerpt

Management of multiple primary cancers, a not so infrequent event in oncology practice, is a critical issue due to the lack of literature . In this study, we reported the case of a patient with metachronous double metastatic non small cell lung cancer (NSCLC) and pancreatic ductal adenocarcinoma (PDAC) who received gefitinib in combination with gemcitabine plus nab-paclitaxel and with mFOLFOX6 in first and second...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: ceb8ec4e-8831-55f8-a4fd-19aca8b8375c
DOI: 10.20944/preprints201905.0173.v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Molecular Characterization of a Long Term Survivor Double Metastatic Non Small Sell Lung Cancer and Pancreatic Ductal Adenocarcinoma Treated with Gefitinib in Combination with Gemcitabine Plus Nab-Paclitaxel and mFOLFOX6 as First and Second Line TherapyDOI 10.20944/preprints201905.0173.v1Read

Long-term disease-free survival of a patient with synchronous bilateral lung adenocarcinoma displaying different EGFR and C-MYC molecular characteristics.Semantic proximity Read

[Synchronous Multiple Primary Lung Cancer Dignosed by Different Phenotype-genotype: A Case Report and Literature Review].Semantic proximity Read

Multiple primary lung cancer displaying different EGFR and PTEN molecular profiles.Semantic proximity Read

[Non-small Cell Lung Cancer with Metachronous Mutations of EGFR and ALK Genes: A Case Report and Literature Review].Semantic proximity Read

[A Patient Surviving More Than Five Years Due to the Effect of Sequential Alternating Chemotherapy Administered to Metachronous Overlapping Cancer of Multiple Myeloma and StageⅣ EGFR Positive Non-Small Cell Lung Cancer].Semantic proximity Read

Synchronous primary lung cancer and epidermal growth factor receptor mutation.Semantic proximity Read

[Multiple synchronous lung adenocarcinoma: Interest of molecular biology for staging].Semantic proximity Read

Different EGFR gene mutations in two patients with synchronous multiple lung cancers: A case report.Semantic proximity Read

Multiple and Concomitant Molecular Findings in a Heavily Treated Patient With EGFR-positive Lung Cancer.Semantic proximity Read

Comprehensive histologic assessment helps to differentiate multiple lung primary nonsmall cell carcinomas from metastases.Semantic proximity Read

A BILATERAL SYNCHRONOUS PRIMARY NON-SMALL CELL LUNG CANCER PATIENT WITH TWO DIFFERENT EGFR MUTATIONSSemantic proximity Read

Case Report: A Bilateral Synchronous Primary Non-Small Cell Lung Cancer Patient With Two Different EGFR Mutations.Semantic proximity Read